|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cashflows provided by operating activities: | ||||
| Net Loss of ZimVie Inc. | ||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Goodwill impairment | ||||
| Share-based compensation | ||||
| Deferred income tax provision | ||||
| Loss on disposal of fixed assets | ||||
| Other non-cash items | ||||
| Gain on sale of spine disposal group (Note 3) | ||||
| Adjustment of spine disposal group to fair value (Note 3) | ||||
| Changes in operating assets and liabilities, net of acquired assets and liabilities | ||||
| Income taxes | ||||
| Accounts receivable | ||||
| Related party receivables | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Accounts payable and accrued liabilities | ||||
| Related party payable | ||||
| Other assets and liabilities | ||||
| Net cash provided by operating activities | ||||
| Cash flows provided by (used in) investing activities | ||||
| Additions to instruments | ||||
| Additions to other property, plant and equipment | ||||
| Business combination investments, net of acquired cash | ||||
| Net cash proceeds from sale of spine disposal group | ||||
| Other investing activities | ||||
| Net cash provided by (used in) investing activities | ||||
| Cash flows used in financing activities | ||||
| Net transactions with Zimmer Biomet | ||||
| Dividend paid to Zimmer Biomet | ||||
| Proceeds from debt | ||||
| Payments on debt | ||||
| Debt issuance costs | ||||
| Repayments of debt due to Zimmer Biomet | ||||
| Payments related to tax withholding for share-based compensation | ||||
| Proceeds from stock option activity | ||||
| Business combination contingent consideration payments | ||||
| Net cash flows from unremitted collections from factoring programs | ||||
| Net activity under employee stock compensation plans | ||||
| Other financing activities | ||||
| Net cash used in financing activities | ||||
| Effect of exchange rates on cash and cash equivalents | ||||
| Decrease in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of year | ||||
| Cash and cash equivalents, end of period | ||||
| Supplemental cash flow information: | ||||
| Income taxes paid, net | ||||
| Interest paid | ||||
| Non-cash settlement of debt due to parent | ||||
| Interest received in-kind | ||||
| Derecognition of right-of-use assets | ||||
| Recognition (derecognition) of right-of-use assets | ||||
| Derecognition of lease liabilities | ||||
| (Recognition) derecognition of lease liabilities |
Loading...
